Background
==========

Coronary chronic total occlusion (CTO) is the last stage of coronary artery atherosclerosis, accounting for one third of the disease confirmed by coronary angiography \[[@B1]\]. CTO exists in about 50% of patients with coronary artery disease, which is often accompanied by complex lesions, in about 15% patients as reported, revealed by coronary angiography \[[@B2]\]. This disease can result in myocardium ischemia, myocardiolysis, reduction of the number of myocardial cells, ventricular remodeling which lead to decreased myocardium contractile, reduction of quality of life and poor prognosis \[[@B3]\]. Medication alone for CTO treatment does reduce the clinical symptom, but it has little effect on the long-term heart function and the improvement of the patients' survival rate. Percutaneous coronary intervention (PCI) is a therapeutic procedure not only used to recanalize vessels with total occlusion \[[@B4]\], but also widely used in other aspects such as increase blood flow reperfusion, improve myocardial contractile and pump function \[[@B5]\], inhibit left ventricular remodeling and decrease adverse cardiac events \[[@B6]\]. However, PCI is considered not suitable for CTO lesions because of the lack in strong backup support by the guiding catheters or the difficulty in taking the contralateral coronary angiograms \[[@B7]\]. The success rate of CTO patients by PCI procedure is lower than that in non-CTO patients \[[@B8]\]. Revascularization for CTO lesions \[[@B9]\] is more difficult and influenced by baseline clinical characteristics, lesions level, intervention equipments and the manipulation techniques \[[@B10]\]. With the development of interventional technologies and physician's manipulation techniques, the successful rate of PCI procedure on CTO lesions is significantly increased \[[@B8]\]. However, CTO recanalization is still accepted as an extremely challenging procedure in cardiovascular PCI treatments.

The success of the recanalization for CTO in coronary interventions is vital \[[@B11]\]. However, the long-term outcomes such as cumulative survival rate, major adverse cardiac events (MACE), incidence of restenosis and reocclusion are still under debate based on different procedures and techniques \[[@B12]\]. Therefore, it is critical to scientifically evaluate the effectiveness and influential factors for CTO interventional treatment.

In this study, publications on PCI procedure in CTO patients were systematically reviewed \[[@B13]\] and suggested potential influential factors that influenced successful rate and outcomes for PCI procedure \[[@B14]\].

Methods
=======

Selection criteria for articles
-------------------------------

Two investigators independently searched Embase, PubMed, Medline, Ovid, CCTR, CNKI, CMBdisc, and with additional manual search for related meeting abstracts and websites including American Heart Association American College of Cardiology, European Society of Cardiology, and national postgraduate thesis pool (from January 1990 to December 2009). The main research key words include "CTO", "PCI", "Stent", "Reopen", "long-term", "follow-up" and "outcome". No language restrictions were used. The inclusion criteria for selected studies comprised: 1) patients with CTO diseases, 2) comparisons of recanalization after PCI and unsuccessful recanalization and 3) the follow-up period of articles were at least one year. Studies with incomplete data or cases number less than 50 were excluded from the analysis.

Data extraction
---------------

Clinical results with prespecified data forms were selected by two independent investigators. Meta-analysis was conducted by two independent clinical experts and the data was pooled by fixed-effect model and random-effect model \[[@B15]\].

Quality assessment
------------------

Two independent investigators assessed the quality of eligible articles according to the Cochrane Handbook \[[@B16]\] with established methods. It includes 5 items: (i) Sequence generation; (ii) Allocation sequence concealment; (iii) Blinding of participants, personnel and outcome assessors; (iv) Incomplete outcome data; (v) Selective outcome reporting.

Statistics analysis
-------------------

The 95% confidence interval (CI) were calculated from abstracted dichotomous data of each study and pooled according to fixed-effects (inverse-variance weighted) and random-effects (DerSimonian and Laird) models. Statistical heterogeneity was assessed with Cochran's Q via a chi-square test and quantified with the I^2^ test, P \< 0.10 and I^2^ \> 50% suggesting significant heterogeneity, I^2^ ≤ 25% considering low heterogeneity. Searching Software for analysis were Comprehensive Meta-Analysis 2.0 and Metanalysis 1.0.

Results
=======

A total of 16 reports \[[@B17]-[@B32]\] during 1990 and 2009 (randomized controlled trials and retrospective studies etc.) were included in consistency with the selection criteria. Totally 6695 cases in successful CTO recanalization (CTO success group) and 2370 cases in failed CTO recanalization (CTO failure group) were included in this study.

Influential factors for CTO recanalization
------------------------------------------

In order to compare clinical and lesion baseline characteristics between CTO success group and CTO failure group, meta-analysis was performed on the studies of CTO revasculization with mean successful rate of 73.9% for CTO recanalization. Eight clinical baseline characteristics (including age, gender, hypertension, hyperlipidemia, diabetes mellitus, smoker, previous myocardial infarction history, previous coronary artery bypass graft surgery (CABG) history) and six lesion baseline characteristics (lesion length, left ventricular ejection fraction, multi-vessel coronary disease, left anterior descending artery lesion, circumflex artery lesion, right coronary artery disease lesion) were analyzed to assess discrepancies between two treatment groups. Among these, weighted average age difference between two groups was 0.083 (95% CI, 0.132 \~ 0.034, P = 0.001, heterogeneity, Q = 31.571, P = 0.005, *I*^2^ = 50.655%) (Figure  [1](#F1){ref-type="fig"}), weighted average lesion length difference was -0.782 (95% CI, -1.499 to -0.065, P = 0.033, Q = 39.806 P \< 0.001, *I*^2^ = 94.976%, Figure  [2](#F2){ref-type="fig"}). The low CTO success rate was associated with previous CABG history (OR 0.707, 95% CI, 0.578 to 0.865, P = 0.001, Q = 1.962 P = 0.854, *I*^2^ = 0.00%, Figure  [3](#F3){ref-type="fig"}) and multi-vessel diseases (OR, 0.649, 95% CI, 0.554 to 0.761, P \< 0.001, Q = 26.943 P = 0.029, *I*^2^ = 44.326%, Figure  [4](#F4){ref-type="fig"}). The other factors including gender, hypertension, hyperlipidemia, diabetes mellitus, smoker, previous myocardial infarction history, left ventricular ejection fraction, left anterior descending artery lesion and circumflex artery lesion did not affect the recanalization rate of PCI on CTO (P \> 0.05).
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The long term effect of PCI on CTO recanalization
-------------------------------------------------

A total of 16 articles were studied on long term outcomes (follow up for more than one year) between CTO success group and CTO failure group. Six follow up variables including MACE, MI, all-cause death, angina pectoris, subsequent CABG and accumulative survival rate were analyzed. CTO success rate was associated with significant reduction in MACE (OR, 0.689, 95% CI, 0.488 to 0.971, P = 0.034, Q = 41.951 P \< 0.001, *I*^2^ = 76.163%, Figure  [5](#F5){ref-type="fig"}), MI (OR, 0.578, 95% CI, 0.387 to 0.864, P = 0.008, Q = 11.80 P = 0.107, *I*^2^ = 40.580%, Figure  [6](#F6){ref-type="fig"}), all-cause death (OR, 0.501, 95% CI, 0.384 to 0.654, P \< 0.001, Q = 28.283 P = 0.012, *I*^2^ = 51.02%, Figure  [7](#F7){ref-type="fig"}), incidence of angina (OR, 0.477, 95%CI, 0.340 to 0.670, P \< 0.001, Q = 12.977 P = 0.043, *I*^2^ = 53 .764%, Figure  [8](#F8){ref-type="fig"}), subsequent CABG (OR, 0.212, 95% CI, 0.175 to 0.257,P \< 0.001, Q = 9.873 P = 0.452, *I*^2^ = 0.00%, Figure  [9](#F9){ref-type="fig"}) and cumulative survival rate (hazard ratio (HR), 0.595, 95% CI, 0.488 to 0.791, P \< 0.001, Q = 11.714 P = 0.039, *I*^2^ = 57.317%, Figure  [10](#F10){ref-type="fig"}).
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Discussion
==========

In this study, a scientific evaluation on the effective of PCI for CTO treatment was carried out. A total of 16 articles involving 6695 cases in successful CTO recanalization (CTO success group) and 2370 cases in failed CTO recanalization (CTO failure group) were included in this research. All the articles were used to identify the factors that influenced the PCI procedure outcome leading to a successful CTO recanalization or failed CTO recanalization. Finally, the clinical baseline characteristics such as age, previous CABG history and lesion baseline characteristics such as lesion length, multi-vessel diseases were considered being the important factors influencing the successful rate of CTO recanalization. Compared to CTO failure patients, the six follow-up variables (MACE, recurrent myocardial infarction, all-cause death, recurrent angina pectoris, subsequent CABG and accumulated survival rate) showed advantage for CTO success patients.

A lot of strategies and devices have been developed for a cure of CTO, but the success rate for each treatment is not consistent \[[@B33]\]. Previous study reveals that PCI significantly improved both the local and global function of the left ventricle in CTO patients \[[@B34]\]. Such procedure is beneficial for the symptom in selected patients \[[@B35]\]. However, NCDR (National Cardiovascular Data Registry) suggested that the attempt rate of PCI on CTO have not changed between 2004 and 2009 in the U.S., even though there are significant advance in the techniques in this area \[[@B36]\], indicating that risks under such procedure and factors affecting the success rate existed. Although the use of PCI for CTO increases recently \[[@B37]\], little systematic study directly compared the failed and success surgery cases with successful recanalization to identify the important factors under PCI. In this study, eight clinical baseline characteristics (age, gender, hypertension, hyperlipidemia, diabetes mellitus, smoker, previous myocardial infarction history and CABG history) and the and six lesion baseline characteristics (lesion length, left ventricular ejection fraction, multi-vessel coronary disease, left anterior descending artery lesion, Circumflex artery lesion and right coronary artery disease lesion) were revealed by directly compared the failed and success surgery cases with successful recanalization. The factors such as age, previous CABG history, lesion length and multi-vessel diseases might be important for the successful rate of CTO recanalization. Long-term patency after recanalization of CTO in patients with angina pectoris is associated with improvement in global and regional left ventricular function \[[@B38]\]. BEPM Claessen et al., \[[@B39]\] revealed that the presence of a CTO is associated with long-term mortality. In this study, six follow up variables including MACE, MI, all-cause death, angina pectoris, subsequent CABG and accumulative survival rate were analyzed by meta-analysis. CTO success was found to be associated with significant benefit in all these factors (Table  [1](#T1){ref-type="table"}), which were consistent with previous studies.

###### 

Characteristics of 16 included studies

  **Study**                   **Year of publication**   **No. of patients**   **No. of patients with successful recanalization**  **Country**    **Occlusion time (month)**   **Clinical follow- up (year)**
  -------------------------- ------------------------- --------------------- ---------------------------------------------------- ------------- ---------------------------- --------------------------------
  Finci \[[@B23]\]                     1990                     200                                  100                          Switzerland                3                              2
  Warren \[[@B18]\]                    1990                     44                                    26                          Australia                  1                             2.6
  Ivanhoe \[[@B19]\]                   1992                     480                                  317                          America                    3                              4
  Noguchi \[[@B20]\]                   2000                     226                                  134                          Japan                      3                             4.3
  Suero \[[@B21]\]                     2001                    2005                                  1491                         America                    1                              10
  Olivari \[[@B22]\]                   2003                     376                                  289                          Italy                      1                              1
  Hoye \[[@B8]\]                       2005                     871                                  567                          Netherland                 1                             4.5
  Drozd \[[@B24]\]                     2006                     459                                  298                          Poland                     1                             2.5
  Prasad \[[@B25]\]                    2007                    1262                                  914                          America                    3                              10
  Aziz \[[@B26]\]                      2007                     543                                  377                          U.K.                       3                             1.7
  Valenti \[[@B27]\]                   2008                     486                                  344                          Italy                      3                              1
  de Labriolle \[[@B28]\]              2008                     172                                  127                          America                    3                              2
  Zhuyanbin \[[@B29]\]                 2008                     115                                   81                          China                      3                              3
  Chenshaoliang \[[@B30]\]             2009                     152                                  132                          China                      3                             1/3
  Yixianhua \[[@B31]\]                 2008                    1604                                  157                          China                      3                              3
  Liubingwei \[[@B32]\]                2008                     41                                    22                          China                      3                              2

Although intervention studies that contain only randomized trials as observational studies are not designed for causal inference, observational studies itself also provide information that may suggest important message in certain circumstance \[[@B40]\]. Compared to the patients in CTO success group in our study, patients in CTO failure group were aged with severe lesion length and multi-vessel diseases. These negative effects made their cases more complicated and leaded to complications as well as the end of procedure ahead of time. These factors might be confounding variables for the analysis of the long term effects after PCI procedure. However, the result of clinical baseline characteristics such as age, previous CABG history, lesion length and multi-vessel diseases were not specific. There was no conclusion on how long of lesion length could be benefit for CTO recanalization, or how old of the patients will have higher successful rate of CTO recanalization. Moreover, limitations also existed in this study such as no bias test and text discrepancy. Meanwhile, a subgroup analysis of time effect on the involved studies was necessary.

Conclusions
===========

The factors including age and CABG history as well as the baseline lesion level (lesion length and multi-vessel diseases) might be the important factors influencing the successful rate of CTO recanalization. The in-hospital mortality, MACE, and incidence of subsequent CABG for PCI procedure were significantly lower in the CTO success group compared with those in the CTO failure group. All six follow up variables (MACE, recurrent myocardial infarction, all-cause death, recurrent angina pectoris, subsequent CABG and accumulated survival rate) showed an advantage for CTO patients with a successful recanalization of occlusions.
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